What’s Going On With Stock On Friday

• Nanobiotix (NASDAQ: NBTX) shares gained more than 200% on Friday trading after it entered into final contract negotiations with a major global pharmaceutical company.

• In its Q4 earnings release, Nanobiotix raised going concerns.

• The company noted net losses of €57.0 million in 2022 and a net decrease in cash and cash equivalents of €42.5 million in 2022.

• Nanobiotix stock is gaining on heavy volume, with a session volume of 30.262 million shares traded.

• The company agreed to a non-binding term sheet for developing and commercializing lead nanotherapeutic candidate NBTXR3 with an undisclosed pharmaceutical company.

• The arrangement is subject to negotiation and execution of a definitive agreement and each party’s requisite internal corporate approvals for the definitive terms.

• Nanobiotix does not intend to make additional statements regarding negotiations unless and until it is appropriate to do so or a final definitive agreement has been signed.

• Price Action: NBTX shares are up 244.8% at $7.00 on the last check Friday.

Don’t miss real-time alerts on your stocks – join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Nanobiotix Stock Triples In Trading Session: What’s Going On With Stock On Friday originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.